Sarepta Therapeutics (SRPT) Other financing activities (2013 - 2025)

Sarepta Therapeutics (SRPT) recorded quarterly Other financing activities of $14.8 million in Q4 2025, up 2568.59% quarter-over-quarter from $554000.0 in Q4 2022.

Sarepta Therapeutics (SRPT) Other financing activities (2013 - 2025) Analysis & Trends

Sarepta Therapeutics' Other financing activities history runs 7 years deep, the most recent figure standing at $14.8 million for Q4 2025.

  • In Q4 2025, Other financing activities changed N/A year-over-year to $14.8 million; the TTM figure through Dec 2025 stood at $15.3 million (up 2668.59% YoY), while the FY2025 annual figure was $17.1 million, changed N/A from the prior year.
  • Other financing activities was $14.8 million for Q4 2025 at Sarepta Therapeutics, up from $554000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $14.8 million in Q4 2025 to a low of $554000.0 in Q4 2022.
  • Historically, Other financing activities has averaged $5.6 million across 3 years, with a median of $1.4 million in 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Sarepta Therapeutics 1.84 Bn 1.16 Bn 291.52 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 14.78 Mn
Dec 31, 2025 14.78 Mn
Dec 31, 2022 554,000.00
Dec 31, 2022 554,000.00
Jun 30, 2021 1.43 Mn
Jun 30, 2021 1.43 Mn
Sep 30, 2019 3.45 Mn
Sep 30, 2019 3.45 Mn
Mar 31, 2019 889,000.00
Mar 31, 2019 889,000.00
Sep 30, 2018 3.30 Mn
Sep 30, 2018 3.30 Mn
Jun 30, 2018 5.75 Mn
Jun 30, 2018 5.75 Mn
Dec 31, 2015 -618,000.00
Dec 31, 2015 -618,000.00
Dec 31, 2013 404,000.00
Dec 31, 2013 404,000.00